| 标题 |
Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Matthew S. Davids; Benjamin L. Lampson; Svitlana Tyekucheva; Zixu Wang; Jessica Lowney; et al 出版日期:2021-09-14 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)